{
    "eid": "2-s2.0-85147143773",
    "title": "Therapeutic options of post-COVID-19 related olfactory dysfunction: a systematic review and meta-analysis*",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Otorhinolaryngology",
            "@code": "2733",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "corticosteroids",
        "COVID-19",
        "olfactory dysfunction",
        "olfactory training",
        "SARS-CoV-2",
        "smell"
    ],
    "authors": [
        "Vararuthai Asvapoositkul",
        "Jompol Samuthpongtorn",
        "Songklot Aeumjaturapat",
        "Kornkiat Snidvongs",
        "Supinda Chusakul",
        "Kachorn Seresirikachorn",
        "Jesada Kanjanaumporn"
    ],
    "citedby-count": 2,
    "ref-count": 43,
    "ref-list": [
        "smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study",
        "Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients",
        "Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19",
        "Six month follow-up of self-reported loss of smell during the COVID-19 pandemic",
        "Olfactory and gustatory dysfunctions in COVID-19 patients: A systematic review and meta-analysis",
        "Olfactory Dysfunction in COVID-19: Diagnosis and Management",
        "Primary care management of post-COVID-19 olfactory dysfunction",
        "A Systematic Review of the Neuropathologic Findings of Post-Viral Olfactory Dysfunction: Implications and Novel Insight for the COVID-19 Pandemic",
        "Post-viral effects of COVID-19 in the olfac-tory system and their implications",
        "Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia",
        "SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes",
        "Changes in olfactory bulbus volume and olfactory sulcus depth in the chronic period after COVID-19 infection",
        "Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options",
        "Neurosensory Rehabilitation and Olfactory Network Recovery in Covid-19-related Olfactory Dysfunction",
        "Dietary supplements and herbal medicine for COVID-19: A systematic review of randomized control trials",
        "Anosmia in the course of COVID-19: A case report",
        "Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations",
        "Olfactory Training for Postviral Olfactory Dysfunction: Systematic Review and Meta-analysis",
        "Clinical Features of Olfactory Dysfunction in COVID-19 Patients",
        "Olfactory Training and Visual Stimulation Assisted by a Web Application for Patients With Persistent Olfactory Dysfunction After SARS-CoV-2 Infection: Observational Study",
        "Effect of nasal corticosteroid in the treatment of anosmia due to COVID-19: A randomised double-blind placebo-controlled study",
        "Comparison of the Healing Effect of Nasal Saline Irrigation with Triamcinolone Acetonide Versus Nasal Saline Irrigation alone in COVID-19 Related Olfactory Dysfunction: A Randomized Controlled Study",
        "Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial",
        "Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial",
        "Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study",
        "Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell",
        "The PRISMA 2020 statement: an updated guideline for reporting systematic reviews",
        "RoB 2: a revised tool for assessing risk of bias in randomised trials",
        "Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?",
        "Randomized clinical trial \"olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin\": preliminary results",
        "Insulin fast-dissolving film for intranasal delivery via olfactory region, a promising approach for the treatment of anosmia in COVID-19 patients: Design, in-vitro characterization and clinical evaluation",
        "Efficacy of corticosteroid therapy in the treatment of long-lasting olfactory disorders in COVID-19 patients",
        "Intranasal photobiomodulation therapy for COVID-19-related olfactory dysfunction: A Brazilian multicenter case series",
        "' Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold",
        "How to assess olfactory performance with the Sniffin' Sticks test(\u00ae)",
        "Updated Sniffin' Sticks normative data based on an extended sample of 9139 subjects",
        "Objective olfactory findings in hospitalized severe COVID-19 patients",
        "Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}